The other ~half of the group are 19-34yos that make 25-75k.
An issue that's just as important, but much more difficult to objectively analyze is the population of underinsured individuals. Those who technically have insurance, but with such minimal coverage that it's essentially useless for anything other than injuries and dismemberment.
In any case, you're correct that insuring everybody isn't going to drastically lower the cost of care. It will some, but not a whole lot. Overall, I think it's safe to say that universal coverage would contribute to overall health improvements. It's difficult to quantify what impact that may have economically or socially, but isn't improving the heath of our citizens the ultimate goal of the entire industry?
Insurance reform isn't our biggest issue, however. Health care delivery reform is what's really needed.
There were/are a few good nuggets within the Affordable Care Act. Specific compensation for physicians to assist with end of life planning is fantastic. It's a very difficult subject for many, and although important, patients often don't like to think about their eventual demise. This can be a cumbersome process for many physicians.
Our health care here will always cost more than it does in the rest of the world. Partly because of the fact that we finance new technology. This is a double edged sword. It's good because we sometimes get some great new stuff, but if you've ever had experience with the medical device world, you know how market driven (as opposed to clinical efficacy driven) it is. A lot of times we pay for expensive new devices that aren't really any more effective but are 10x more expensive. Sometimes we even get detrimental products, such as the metal on metal hip implants. Devices only have to prove to the FDA that they're not harmful. They don't do any sort of efficacy or "value" assessments on them. Of course each company peddles their new product like it's the greatest invention since the coronary stent. A lot of European countries are slower to adopt new technologies, but most of them also have an agency that evaluates each item to make sure it is actually worth paying the $$$ for it.
I'm digressing a bit here. I'm a little tired of typing but I could go on for hours about care delivery.
An issue that's just as important, but much more difficult to objectively analyze is the population of underinsured individuals. Those who technically have insurance, but with such minimal coverage that it's essentially useless for anything other than injuries and dismemberment.
In any case, you're correct that insuring everybody isn't going to drastically lower the cost of care. It will some, but not a whole lot. Overall, I think it's safe to say that universal coverage would contribute to overall health improvements. It's difficult to quantify what impact that may have economically or socially, but isn't improving the heath of our citizens the ultimate goal of the entire industry?
Insurance reform isn't our biggest issue, however. Health care delivery reform is what's really needed.
There were/are a few good nuggets within the Affordable Care Act. Specific compensation for physicians to assist with end of life planning is fantastic. It's a very difficult subject for many, and although important, patients often don't like to think about their eventual demise. This can be a cumbersome process for many physicians.
Our health care here will always cost more than it does in the rest of the world. Partly because of the fact that we finance new technology. This is a double edged sword. It's good because we sometimes get some great new stuff, but if you've ever had experience with the medical device world, you know how market driven (as opposed to clinical efficacy driven) it is. A lot of times we pay for expensive new devices that aren't really any more effective but are 10x more expensive. Sometimes we even get detrimental products, such as the metal on metal hip implants. Devices only have to prove to the FDA that they're not harmful. They don't do any sort of efficacy or "value" assessments on them. Of course each company peddles their new product like it's the greatest invention since the coronary stent. A lot of European countries are slower to adopt new technologies, but most of them also have an agency that evaluates each item to make sure it is actually worth paying the $$$ for it.
I'm digressing a bit here. I'm a little tired of typing but I could go on for hours about care delivery.

Comment